Ribavirin for Chronic Hepatitis E Virus Infection in Transplant Recipients
2014; Massachusetts Medical Society; Volume: 370; Issue: 12 Linguagem: Inglês
10.1056/nejmoa1215246
ISSN1533-4406
AutoresNassim Kamar, Jacques Izopet, Simona Tripon, Michaël Bismuth, Sophie Hillaire, Jérôme Dumortier, Sylvie Radenne, Audrey Coilly, Valérie Garrigue, Louis d’Altéroche, Matthias Büchler, Lionel Couzi, Pascal Lebray, Sébastien Dharancy, Anne Minello, Maryvonne Hourmant, Anne‐Marie Roque‐Afonso, Florence Abravanel, Stanislas Pol, Lionel Rostaing, Vincent Mallet,
Tópico(s)Viral gastroenteritis research and epidemiology
ResumoThere is no established therapy for hepatitis E virus (HEV) infection. The aim of this retrospective, multicenter case series was to assess the effects of ribavirin as monotherapy for solid-organ transplant recipients with prolonged HEV viremia.
Referência(s)